37 - CMC Considerations in Preclinical Stage (S3E7)

Welcome back to the deep dive, where we do a
deep dive into really complex topics. And today
we're going behind the scenes kind of early stage
drug development and exploring a stage that's
super important, but a lot of times overlooked.
Chemistry, manufacturing, and controls. CMC for
short. CMC, that's right. You see, before a new
medicine hits the market, it goes through a ton
of testing and development. And CMC is really
important to make sure that the drug is safe
and effective, but also that it can be manufactured
reliably and on a big scale. Yeah, it's really
all about taking a recipe from your kitchen.
You can make an amazing dish in small batches,
but then how do you make sure that the quality
and the taste are the same when you scale it
up to hundreds of thousands of people? Oh, that's
a great analogy, yeah. That's the essence of
CMC, taking that promising drug candidate from
the lab and figuring out how to make it consistently
and on a scale that can actually help patients.
Yeah, no, that's perfect. That makes a lot of
sense. And to help us through this really complicated
world, we have an expert in CMC joining us today.
They're gonna help us understand like all the
ins and outs of candidate quality scalability
and how organizations like the FDA and ICH kind
of shape the landscape even at this early preclinical
stage. Yeah, shaping the landscape early on is
really important. So let's dive right in. Can
you tell us why CMC is so important in the preclinical
phase? Like, what are the main things that researchers
are trying to get done at this point? So one
of the big goals of preclinical CMC is we call
it candidate quality. What that means is making
sure that every batch of the drug candidate is
the same, pure, stable, and has all the right
properties to be effective. It's all about getting
rid of any variability and making sure that what
worked in the lab actually works when you start
making more of it. So that brings us to scalability,
right? Like we need to show that the manufacturing
process can be scaled up to make larger amounts
of the drug, but you know. without messing up
that quality that we were just talking about.
Exactly, it's not enough to just show that the
drug works. You gotta show that you can make
enough of it to meet demand, you know, potentially,
without any drop in quality or how well it works.
Yeah, yeah, I know that makes perfect sense.
Now, I know that lab scale synthesis is usually
where drug development begins. Can you talk a
bit about, like, the specific problems researchers
run into when they're working this really small
scale? Yeah, for sure. Lab scale synthesis definitely
has its own set of challenges. Like, just think
about the availability and cost of starting materials.
OK. In the lab, researchers might use very specific
ingredients to create a small amount of the drug.
But those ingredients can be expensive or hard
to get in the amounts you would need for mass
production. Well, that makes sense. So finding
other materials that work or changing how the
drug is made to use easier to get materials,
that becomes really important. So it's like you're
already thinking about the future. Exactly. Even
though you're working on a small scale. Right.
And then there's the complexity of the synthesis
process itself. Lab scale synthesis often has
a bunch of steps, and each step could have errors
or variations. Oh, so it's not a simple, like,
one -step process. Right, exactly, yeah. Scaling
up a process with many steps can be super tough
and expensive. That makes sense. So researchers
need to think early on about how to simplify
the process and make it more streamlined to make
it more efficient and less expensive for large
-scale production. It seems like CMC is all about
seeing roadblocks before they even pop up, right?
Are there certain strategies researchers can
use in this early process development phase to
tackle these challenges? Absolutely. It's all
about being proactive. One major strategy is
to, like we said before, optimize the synthesis
route. That might mean finding easily available
and affordable alternatives to those rare or
expensive starting materials. Another thing is
reducing the number of steps in the synthesis
process. Each step adds complexity and the chance
for errors. So simplifying things can really
boost scalability and cut down on manufacturing
costs. So less is more in a lot of cases. Often,
yeah. And it's not just about efficiency. We
also got to think about sustainability. Things
like the environmental impact, waste disposal,
even in these early stages. manufacturing is
a core idea in CMC. So even at the pre -clinical
stage, researchers are already thinking about
the long -term impact of their work. Exactly.
It's not just about creating a drug. It's about
creating one that can be produced in a way that's
sustainable and responsible. Got it. Now let's
switch gears a bit and talk about organizations
like the FDA and ICH. How do their guidelines
impact CMC? in the preclinical stage. You know
it's really interesting how these organizations
are shaping the future of medicine before we
even get to the first human trial. their guidelines
act like a framework to make sure that drug development
focuses on safety, efficacy, and quality right
from the start. It's like having a blueprint
to guide the whole process, helping researchers
avoid those, you know, really costly and time
-consuming setbacks later on. So it's not just
about, you know, being really good at science.
It's also about following a strict set of rules
that make sure the final product meets those
high standards for quality and safety. Exactly.
And these guidelines are not just you know, theoretical
ideas, they really impact how preclinical CMC
work is done. Can you give us some real world
examples of how these regulations play out in
practice? Sure. Let's talk about safety. A big
part of CMC is doing lots of tests to make sure
that the drug and how it's made are safe for
people. This means figuring out if there's any
potential for toxicity, impurities or anything
else that could be risky for patients. So before
we even think about giving the drug to a person.
Right. We got to be sure it's made in a way that
minimizes any potential harm. Exactly. And it's
not just about the drug itself. It's about the
whole process of making it. Right. Right. The
FDA and ICH guidelines also talk about good manufacturing
practices or GMP. And these practices are there
to make sure that the manufacturing facilities
and the ways things are done meet really strict
standards to reduce the risks of contamination
and keep the quality and consistency of the drug
product high. Right. It's a very thorough approach
that covers everything from the raw materials
all the way to the final packaged product. Wow.
That's amazing. It really highlights the incredible
attention to detail that goes into drug development,
even at this early preclinical stage. Oh, absolutely.
This carefulness is crucial for building trust
in the medicines we rely on. Knowing that every
step has been scrutinized and validated gives
us confidence in the final product. Absolutely.
Speaking of building trust, let's talk about
efficacy. How do researchers show that a drug
candidate is actually doing what it's supposed
to do during this preclinical phase? So efficacy
is about showing that the drug actually works.
Preclinical studies are set up to show that the
drug has the desired effect, you know, in a controlled
environment. Okay. This might mean testing the
drug in animals or using systems in the lab to
see how it affects cells or tissues. So gathering
evidence that the drug is working the way it
should. Exactly. It's like laying the groundwork
for later clinical trials in people. And this
evidence has to be really solid, right? Oh yeah,
absolutely. And that's where those ICH guidelines
on how to do statistics for clinical trials come
in. Right. They make sure that the information
collected is sound and can be used to make smart
decisions about whether to keep developing the
drug. Exactly. It's all connected from those
first steps of making the drug in the lab to
the rigorous testing and analysis that prove
the drug safety and how well it works. And all
of this is happening before the drug even gets
to a human patient. Right. It really underscores
how important CMC is in this preclinical stage
as the foundation for everything that comes after.
It is the foundation, yeah. And speaking of foundations,
let's talk about quality. We've touched on this
a bit, but can you explain what quality means
in the context of preclinical CMC? Quality in
CMC is all about consistency. It's about making
sure that even as you scale up the manufacturing
process, you're still producing a high quality
medicine that meets those tough safety and efficacy
standards we talked about. Right. This means
using GMP to minimize contamination risks and
make sure each batch of the drug is uniform and
meets the specs that were set beforehand. So
it's not just about making the drug. It's about
making it the right way every time. Exactly.
It's about having a process that's reliable.
and can be reproduced, ensuring that the final
product is top notch and gives researchers and
patients confidence that it's safe and effective.
Absolutely. And this focus on quality goes beyond
just the manufacturing process, right? It also
includes things like testing to see how stable
the drug is, ensuring that it maintains its potency
and purity over time. You're absolutely right.
Stability testing is really important in CMC.
It means exposing the drug to various conditions
like different temperatures and humidity levels
to see how it breaks down over time. This information
is key for figuring out the shelf life of the
drug and making sure it stays effective and safe
for patients. So even after the drug is made,
the CMC work continues to make sure it stays
high quality and stable. Yeah, it's like a continuous
cycle of testing, analyzing, and refining, all
focused on getting the best possible medicine
to patients. Wow, it's really a continuous process.
It is. And it's important to remember that all
this meticulous work is happening behind the
scenes, long before a medicine is even available
to the public. It's a testament to how dedicated
and skilled CMC professionals are. Absolutely,
yeah. They work so hard to make sure new treatments
are safe, effective, and reliable. It's a critical
part of drug development, but it doesn't always
get the attention it deserves. Yeah, definitely
not. It's amazing how much thought and effort
goes into every single step of the process. It
really is. And speaking of fascinating parts
of the process, let's dig a little deeper into
the analytical techniques they use in preclinical
CMC. These techniques are key for figuring out
the quality and purity of drug substances. They
are, yeah. I'm particularly curious about the
idea of sensitivity in these analytical procedures.
Why is sensitivity so important in this context?
What makes a good analytical method really stand
out? Sensitivity is super important in preclinical
CMC because we're often working with tiny amounts
of the drug substance at this stage. If a method
is highly sensitive, it can detect even the smallest
traces of the drug or impurities, which allows
us to really accurately assess its purity, stability,
and ultimately its safety. Oh. It's like having
a super powered microscope that can spot even
the tiniest flaws or inconsistencies in the drug
substance. So the more sensitive the method,
the more confident we can be about the drug's
quality and purity. Precisely. And just like
a microscope has to be calibrated for accuracy,
analytical methods have to be validated. That
means proving that the method is accurate, reliable,
and gives the same results consistently every
single time. So it's not just about having the
fancy tools, it's about making sure those tools
are working right and giving us information we
can trust. Exactly, that's what validation is
all about. It's a critical step to make sure
the data we're using to make decisions about
the drug's development is trustworthy and accurate.
Okay, we've talked a lot about the technical
side of CMC, but let's not forget about the people
involved. What kind of expertise do you need
to navigate this complex world? What are the
different roles that contribute to making pre
-clinical CMC successful? It's a field that really
requires people from different areas of expertise
to work together. At the heart of it all, you
have chemists who are the experts in how drugs
are made and how to change those processes to
work on a larger scale. They're the ones who
come up with the recipes, you could say, always
trying to make the process better and ensure
high quality. And to make sure those recipes
are followed perfectly, we need analytical chemists,
right? Absolutely. They're the quality control
specialists. They develop and validate those
really sensitive testing methods we discussed
earlier, making sure that every batch of the
drug is consistent and pure. So it's like they're
making sure the ingredients are measured out
exactly right every single time. Exactly, yeah.
And to take those lab scale processes and make
them work in a factory, we need chemical engineers.
They're the ones who bridge the gap between the
lab and the factory, designing and scaling up
the manufacturer processes so we can make large
quantities of the drug. It's amazing how it takes
so many different people with different skills
to make this all work. It's a true team effort.
And then there are the regulatory experts who
make sure everything is done according to the
FDA and ICH guidelines. They're like the conductors
of the orchestra, making sure everyone is playing
the same tune. Exactly. Keeping everything in
sync. So it's this huge collaborative effort
that involves scientists, engineers and regulatory
specialists all using their expertise to make
preclinical CMC successful. It really is, yeah.
And this collaboration is key to navigating all
the complexities of drug development and making
sure new treatments meet the highest standards
of safety, efficacy, and quality. It's a journey
with lots of moving parts, but ultimately it's
all about helping patients. Absolutely. Speaking
of standards, let's get back to the ICH guidelines
and their impact on drug development. Can you
give us some specific examples of how these guidelines
actually influence how a new medicine is developed?
Sure. One great example is the ICH Q3A guideline,
which is all about impurities in new drug substances.
This guideline sets limits on the types and amounts
of impurities that are allowed in a drug, which
helps to minimize the risk of those impurities
harming patients. So it's like setting a tolerance
for imperfections? Yeah. Exactly. We can't expect
perfect purity, but we need to make sure that
any impurities are within safe limits. That makes
sense. And ICH guidelines don't just focus on
safety. They cover things like efficacy, too.
For example, the ICH E9 guideline provides guidance
on statistical principles for clinical trials,
helping to ensure that the data we collect is
strong and reliable and that the effectiveness
of the drug is assessed properly. So it's really
a comprehensive approach, covering everything
from the very beginning of drug development to
those final clinical trials. Exactly. And it's
important to remember that these guidelines are
always evolving as our knowledge of drug development
and the science behind it changes. So it's not
like a set in stone rule book. Right. Exactly.
It's more like a dynamic framework that adapts
to new knowledge and challenges. It's always
trying to make the process better and make sure
new medicines are developed to the highest standards
possible. It's really amazing to see how much
thought and effort goes into making sure new
medicines are safe and effective. It highlights
just how important these behind -the -scenes
processes are, even if most people don't know
about them. It really does. And it's not just
about the science. It's about the people, the
collaboration, and the commitment to quality
that makes new treatments possible. Absolutely.
The development of a new medicine is an incredible
journey. It's full of challenges, setbacks, but
ultimately successes. And CMC in the pre -clinical
stage is crucial in shaping this journey. It
lays the foundation for safe and effective treatments
that have the potential to really change lives.
It truly is the foundation. And speaking of potential,
let's think about things from the patient's perspective.
Why should all of this matter to someone who's
not a scientist or researcher? What's the takeaway
for the average person who might one day need
these new treatments? That's a great point. What
is the takeaway for the everyday person? I think
the main takeaway is this. When you hear about
a new medicine being approved and made available,
it's easy to forget about all the hard work that
went into making that happen. CMC in the pre
-clinical stage is a huge part of that journey.
It's about making sure that the medicine is safe,
effective, and produced consistently to the highest
possible standards. It's about making sure we
can trust the medicines we rely on. Exactly.
And it's a process that takes a lot of planning,
testing, and collaboration between experts from
different areas. Might not be the most exciting
part, but it's absolutely essential for delivering
high quality health care. It really is. So the
next time you hear about a brand new treatment,
remember the CMC folks who work so hard to make
it happen. They might not be in the spotlight,
but they're a big reason why we have these new
medicines. They are the unsung heroes. And on
that note, I want to thank you, our expert, for
coming on today and sharing your knowledge about
this fascinating and complex world. It was my
pleasure. Thanks for having me. And to our listeners,
thanks for joining us on the Deep Dive. We encourage
you to check out the show notes for more information
and resources. Until next time, keep diving deeper.
Yeah, it is a reminder that science is like always
moving forward, always learning, refining, and
adapting to new challenges. Speaking of challenges,
let's zoom in on... a specific aspect of CMC
that is super important for ensuring those high
standards that we keep talking about, analytic
techniques. Okay. Analytical techniques are like,
I don't know, the eyes and ears of CMC. They
allow scientists to really examine the drug substance
at a molecular level. That's a good way to put
it. Can you tell us a bit more about the role
of these techniques in preclinical CMC? What
kind of information are scientists trying to
get? Analytical techniques, they're essential
for characterizing and quantifying different
aspects of the drug substance. Things like its
purity, stability, and even its physical properties.
Like for example, we use techniques like chromatography.
It helps us separate and identify different parts
of the drug substance. And that helps us ensure
that the drug is pure and doesn't have any impurities
that we don't want in there. And then we have
other techniques like spectroscopy that allow
us to study the structure and composition of
the drug substance. gives us valuable information
about its stability and how it might break down
over time. So it's like having a whole bunch
of different tools, each one giving you a different
piece of the puzzle. Exactly. And the information
we get from these analytical techniques is used
to make important decisions about how the drug
is developed, from tweaking the manufacturing
process to deciding how to store it properly.
And how do these techniques relate to those regulatory
guidelines we discussed earlier? So the FDA and
ICH guidelines, they have very specific standards
for the analytical methods that can be used in
drug development. For example, the ICH Q2 guideline,
it provides guidance on something called method
validation. Basically, it's about making sure
that the analytical methods used are accurate,
reliable. and doing what they're supposed to
do. So it's kind of like a quality check for
the tools themselves. Exactly. Yeah. This validation
process really helps to make sure that the data
coming from these analytical techniques is trustworthy
and meets those regulatory requirements. It's
crucial. So again, it's not enough to just have
fancy equipment. Right. It's about using that
equipment in a way that meets those high quality
standards and gives us reliable data. Absolutely.
And this focus on detail is really important
for making sure new medicines are safe and effective.
Now, we talked about how complex CMC is and how
it needs people with very specific skills. Can
you give us a peek into the world of CMC professionals?
Like, what are some of the different roles that
contribute to this process? Well, CMC is all
about collaboration, bringing together experts
from many different fields. You've got organic
chemists who focus on developing and optimizing
the way the drug substance is made. They're the
ones who work hard to figure out the most efficient
and cost -effective way to produce the drug,
all while maintaining its purity and quality.
So they're like the master chefs of the drug
world. Yeah, you could say that. Then you've
got analytical chemists who are like the guardians
of quality control. They develop and validate
those sensitive testing methods we talked about,
making sure each batch of the drug meets those
specific requirements. And then to take those
processes from the lab to a larger scale, you
need chemical engineers, right? Exactly. They're
the ones who design and optimize the manufacturing
process, making sure the drug can be produced
in large quantities without compromising its
quality. So it sounds like a well coordinated
team effort is crucial here. Oh, absolutely.
It really is like an orchestra with everyone
playing their part to create a harmonious final
product. I love that analogy. Right. And of course,
we can't forget the regulatory affairs professionals.
They make sure all this work is done according
to those guidelines from the FDA and ICH. Right.
They're the ones who keep everyone on track and
make sure. everything needs the regulations.
So it's this really interdisciplinary field that
requires everyone to work together and be committed
to quality. Exactly. And that team spirit is
essential for tackling the challenges that come
up during drug development and ultimately getting
new treatments to the people who need them. Speaking
of challenges, what are some of the hurdles CMC
teams often face in the preclinical stage? Like,
what are some common roadblocks and how do they
get around them? Well, one of the biggest challenges
is finding a manufacturing process that can be
scaled up and isn't too expensive. OK. You see,
early on, researchers might use materials that
are pricey or hard to get to make the drug in
the lab. But as the drug gets closer to clinical
trials and potentially being sold, the process
needs to change so we can make bigger quantities
without spending a fortune. So it's like a balancing
act between keeping the quality high and making
sure it's affordable to produce. Exactly. It
often involves finding different starting materials,
tweaking the conditions of the reactions, or
even completely redesigning how the drug is made.
Interesting. And then there's the challenge of
making sure the drug is stable. Like we said,
stability testing is super important to figure
out how long the drug will last and make sure
it stays safe and effective over time. Right.
But some drugs are naturally unstable, which
makes it really tricky to turn them into a product
that lasts. Oh, I see. This might mean using
special packaging, storing them carefully, or
even coming up with completely new ways to deliver
the drug to protect it from breaking down. So
it's not just about making the drug, it's about
making sure it stays good until it gets to the
patient. Exactly. And tackling these challenges
takes a combination of scientific smarts, creative
problem solving, and a deep understanding of
the drug itself and all the regulations involved.
Now, we've talked a lot about the technical side
of CMC, but it's important to remember that all
of this is ultimately about helping people. It
is. Can you talk about the connection between
preclinical CMC and the patient experience? How
does all this work behind the scenes actually
benefit the people who might one day take these
new treatments? Preclinical CMC plays a big role
in shaping the patient experience, even though
it happens long before the drug is available.
By making sure the manufacturing process is high
quality, safe, and can be scaled up, CMC teams
are setting the stage for a reliable and consistent
supply of the medication. OK. This means patients
can feel confident about the quality of the drug
they're getting, knowing it's been made to the
highest standards. Right. It's about building
that trust. Exactly. And by making the manufacturing
process as good as it can be, CMC teams can also
help to bring the cost of making the drug down,
which makes it more accessible to more people.
So it's not just about the science itself. It's
about making sure those scientific advances actually
help people in the real world. Right. It's about
having a positive impact on patients' lives.
Now, Let's zoom out a bit and look at drug development
as a whole. Where does preclinical CMC fit into
the whole pipeline? What are the big milestones
and transitions that mark this stage? Preclinical
CMC is essentially the bridge between discovering
a drug and actually testing it in clinical trials.
Once scientists find a promising drug candidate
in the lab, CMC teams jump in to figure out how
to manufacture it in a way that's reliable and
can be scaled up. This involves a lot of different
activities, like optimizing the synthesis route,
doing the stability tests, and basically making
sure that the drug substance can be produced
consistently and to the required quality standards.
So it's about taking that initial discovery and
turning it into something that can actually be
made on a larger scale. Exactly. And this preclinical
CMC work usually happens at the same time as
preclinical toxicology studies, which look at
how safe the drug is in animals. Once both the
CMC and toxicology studies have enough data to
show that the drug candidate is safe, the team
can start preparing for the next big step, submitting
an investigational new drug, IND, application
to the FDA. The IND, right? Yeah. This application
is like a big report that summarizes all the
pre -clinical data that supports the safety of
the drug candidate, as well as the plan for the
clinical trial and how the drug substance will
be made. So it's like a checkpoint where you
transition from working in the lab to testing
the drug in people. Righter, exactly. And a lot
depends on the quality of the preclinical CMC
data in that IND application. OK. If the FDA
has any concerns about the manufacturing process
or the quality of the drug substance, they might
put the clinical trial on hold until those concerns
are addressed. So it's a really important step
that shows just how important it is to be careful
and thorough during preclinical CMC. Absolutely.
everything has to be done right. It's incredible
how much goes into getting ready for those first
human trials. It is, yeah. And it reminds us
that drug development is a long and complicated
process. It is, yeah. With each stage building
on the one before it. That's right. Now we've
talked about the regulatory hurdles and the scientific
challenges, but what about the people doing this
work? What are some of the things that motivate
CMC professionals? What makes this work rewarding
for them? I think for many CMC professionals,
it's the feeling of being part of something bigger
than themselves. Oh, yeah. Knowing that what
they do is helping to create new treatments that
have the potential to reduce suffering and improve
people's lives. That's a powerful motivator.
Absolutely. It's also a field that's always pushing
the boundaries of innovation and problem solving.
CMC teams are always looking for new and better
ways to produce these complex drug substances,
often using cutting edge technology. technologies
and techniques. It sounds like a really exciting
field to be in. It definitely is. And we can't
forget about the collaborative aspect of CMC.
Teams are usually made up of people from different
backgrounds, each with their own expertise. Right,
the diversity of thought is so important. It
creates a dynamic and stimulating environment
where everyone is working together towards a
shared goal. And that shared goal is ultimately
to help patients. Exactly. So it's a field that
offers both intellectual challenges and a deep
sense of purpose, all while making a real difference
in the world. It's really inspiring to see the
passion and dedication of CMC professionals.
It is. And it's a good reminder that behind every
groundbreaking new medicine is a team of people
who worked incredibly hard to make it happen.
That's true. Speaking of those dedicated folks,
let's take a moment to acknowledge the contributions
of analytical chemists in CMC. Yes, they are
essential. We touched on their role in quality
control, but can you talk more about the specific
challenges and rewards of this specialized field?
Analytical chemistry is like the backbone of
CMC. It provides the data that drives all the
decisions made throughout the process. Analytical
chemists, they're the ones who develop and validate
those really sensitive analytical methods we
discussed earlier. They make sure the drug substance
meets strict quality standards. So they play
a critical role. in ensuring the drug is safe
and effective. Absolutely. It's a very meticulous
and demanding field that requires a deep understanding
of chemistry, instrumentation, and how to analyze
data. So you need a really strong foundation
in chemistry to do this work. Definitely. Analytical
chemists are constantly challenged to find new
and better ways to measure and characterize these
complex drug substances. They often work with
cutting edge technology and push the limits of
what's possible in terms of detection. So they're
really pushing the boundaries of science. They
are. It's a field that demands precision, accuracy,
and a real commitment to quality. It sounds like
there's no room for error. Not really, no. But
it's also a field that brings a lot of satisfaction.
Knowing that your work is directly contributing
to the safety and effectiveness of new medicines
is a huge motivator. Absolutely. And seeing the
data you've collected being used to make crucial
decisions about drug development is incredibly
rewarding. So it's a field that's both intellectually
stimulating and deeply meaningful. It's amazing
to see how much passion and expertise goes into
every part of CMC. It really is. And it's a reminder
that even the smallest details have a big impact
on the success of developing new medicines. Speaking
of details, let's delve a little deeper into
those analytical techniques. Can you give us
some specific examples of the tools and methods
that analytical chemists use to analyze drug
substances? Analytical chemists have a whole
range of tools and techniques at their disposal,
each one designed to provide unique information
about the drug substance. One of the most common
techniques is chromatography, which is used to
separate and identify the different components
within a mixture. There are different types of
chromatography, like high -performance liquid
chromatography or HPLC. and gas chromatography,
GC for short. And each one is best suited for
different types of drug substances. Gotcha. Chromatography
is really important for assessing how pure the
drug substance is, finding any impurities that
might be lurking in there, and seeing how stable
the drug is over time. So it helps to paint a
complete picture of the drug substance. Exactly.
And then we have spectroscopy, which uses light
to study the structure and composition of molecules.
There are different kinds of spectroscopy, too,
like ultraviolet visible spectroscopy, UVVs,
infrared spectroscopy, IR, and nuclear magnetic
resonance spectroscopy, NMR. Wow, that's a lot
of different techniques. Each type of spectroscopy
gives us different pieces of information about
the drug substance, like what functional groups
it has, its three -dimensional structure, and
how it interacts with other molecules. So it's
like having different lenses to look at the drug
substance from different angles. Precisely. And
all this information is used to build a comprehensive
profile of the drug substance, ensuring that
it's high quality, safe, and effective. It's
amazing how much information you can get from
these techniques. It really is, and it shows
how clever analytical chemists are developing
these powerful tools to examine drug substances
at such a tiny level. Speaking of scrutiny, let's
talk about method validation again in analytical
chemistry. We touched on this earlier, but can
you explain why method validation is so important
in CMC? Method validation is all about proving
that an analytical method is doing what it's
supposed to do. In CMC, it's crucial for making
sure that the data from these analytical techniques
is accurate, reliable, and meets those regulatory
standards. So it's about making sure the data
we're using to make decisions is trustworthy.
Exactly. The ICH Q2 guideline provides a framework
for how to do method validation. It outlines
the things you need to check, like... accuracy,
precision, linearity, and robustness. That's
like a checklist to make sure the methods are
up to par. Exactly. This rigorous validation
process helps ensure that the analytical methods
used in CMC are reliable and produce data that
we can trust. And that trustworthy data is essential
for making informed decisions about drug development,
right? Absolutely. It helps us do everything
from optimizing the manufacturing process to
making sure the drug substance is safe and effective.
So without method validation, we wouldn't know
if the data from these analytical techniques
is actually reliable. That's right. And that
could lead to serious problems in drug development,
potentially even putting patients at risk. It's
like building a house on a foundation that's
not stable. Exactly. If the foundation isn't
solid, the whole structure could collapse. So
method validation is crucial. for making sure
the whole CMC process is sound and reliable.
It's a fundamental part of the process. It's
amazing how much attention to detail goes into
every single aspect of CMC. It's all about quality.
It's a reminder that even the tiniest details
can make a huge difference in whether a new drug
is successfully developed. Every step matters.
Speaking of specifics, let's look at some real
-world examples of how analytical techniques
are used to solve challenges in CMC. Okay. Can
you share any case studies or stories that highlight
how important these techniques are? Sure. One
great example is how analytical techniques are
used to find and measure impurities in drug substances.
Impurities can come from all sorts of places,
like the starting materials, the manufacturing
process, or even the drug breaking down over
time. So it's like contamination? In a way, yeah.
And some impurities might be harmless, but others
can be toxic or even make the drug less effective.
That makes sense. Analytical techniques like
chromatography and spectroscopy, they're key
for finding and measuring these impurities. This
allows CMC teams to keep an eye on the levels
of impurities and make sure they stay within
safe limits. So they're like the detectives of
the drug development world? Yeah. For example,
while developing a new cancer drug, analytical
chemists found a tiny impurity that was causing
the drug to break down really quickly. Oh, wow.
They used a combination of chromatography and
septroscopy to identify the impurity, figure
out where it was coming from, and then change
the manufacturing process to get rid of it. So
they were able to solve the problem. Exactly.
This ensured that the drug stayed stable and
effective, which allowed them to continue developing
it for clinical trials. That's a great example
of how important these techniques are. It really
is. And another example is how we use analytical
techniques to assess how stable a drug substance
is. Right. We talked about stability testing
earlier. Exactly. It's really important for figuring
out the shelf life of a drug and making sure
it stays safe and effective for as long as possible.
Analytical techniques like HPLC and UV -VIS spectroscopy
are commonly used to track how the drug substance
breaks down under different conditions. Like
different temperatures and humidity levels. Right.
And this data is used to figure out the best
way to store the drug and what kind of packaging
to use to protect it from breaking down. So it's
not just about making the drug, it's about making
sure it stays... potent and safe until it reaches
the patient. Exactly. Analytical techniques are
crucial for understanding how the drug behaves
over time. It's fascinating how these techniques
are used to tackle real -world problems in CMC.
It is. And it's a good reminder that the work
of analytical chemists is really important for
getting safe and effective medicines to people.
They're unsung heroes for sure. Absolutely. Speaking
of the people who benefit from all this work,
let's take a moment to think about the impact
of CMC on patients. Okay. How does all this behind
-the -scenes effort translate into real benefits
for the people who might one day take these new
treatments? Well, At its heart, CMC is about
ensuring that new medicines are developed and
made to the highest standards of quality, safety,
and efficacy. By optimizing the manufacturing
process, doing rigorous stability testing, and
putting in place strong quality control measures,
CMC teams are creating the foundation for treatments
that are reliable and consistent. So it's about
giving patients confidence that the medicines
they're taking are safe and effective. Exactly.
Patients need to know that the medicines they
rely on have been made with incredible attention
to detail and that they meet strict regulatory
guidelines. It's about building trust in the
health care system. It is. And by streamlining
the manufacturing process and finding ways to
make it more cost effective, CMC teams can also
help to make new treatments more affordable and
accessible to more people. So it's not just about
the science. It's about making sure that everyone
who needs these treatments can actually get them.
That's right. The work of CMC has a direct impact
on people's lives, making sure they have access
to medicines that are safe, effective, and affordable.
It's a powerful reminder that even the most technical
aspects of drug development are ultimately about
improving human health. Absolutely. At the end
of the day, it's all about helping people. Speaking
of improving human health, let's shift our focus.
to the bigger picture of innovation in the pharmaceutical
industry. Okay. How has CMC changed over time
and what are some of the new trends and challenges
emerging in this field? CMC has come a long way
in the last few decades thanks to advances in
science, new technologies, and evolving regulations.
One of the biggest trends is that the drug substances
we're working with are getting more and more
complex. As we try to develop treatments for
really challenging diseases like cancer and Alzheimer's,
the molecules themselves are becoming more complicated
and harder to manufacture. So the science is
getting more challenging. It is. This has led
to the development of new synthesis methods,
advanced analytical techniques, and more sophisticated
manufacturing processes to handle this complexity.
So CMC is having to adapt to keep up with these
advances. Exactly. Another trend is the growing
focus on something called quality by design,
or QBD for short. It's a way of thinking about
drug development where you focus on building
quality into the product from the very beginning.
So it's about getting things right from the start.
Exactly. It involves understanding the critical
quality attributes, or CQAs, of the drug substance
and designing the manufacturing process to consistently
deliver those CQAs. So you're thinking about
quality at every step of the way. Exactly. And
QBD has led to improvements in process control,
less variability, and ultimately, medicines that
are of a higher quality. That makes sense. And
there's also a growing interest in continuous
manufacturing. Traditionally, drugs are made
in batches, where each batch is produced and
tested separately. But continuous manufacturing
is a more streamlined process, where the drug
substance is made continuously, with monitoring
and control happening in real time. So it's a
more efficient way of doing things. It is. Continuous
manufacturing has a number of advantages, like
shorter manufacturing times, increased efficiency,
and better quality control. So it's a win -win
situation. Pretty much, yeah. So CMC is a really
dynamic and constantly evolving field, always
adapting to new challenges. Exactly. Successful
CMC professionals are usually very detail -oriented,
meticulous in their work, and driven by a desire
to make the best possible product. So they're
perfectionists in a way. In a way, yes. They
also need excellent communication skills because
they often have to collaborate with colleagues
from different areas, as well as with regulatory
agencies. So being able to explain complex things
clearly is important. It is. And they also need
to be adaptable and able to think critically
to overcome challenges and come up with creative
solutions to complex problems. So it's a field
that requires a lot of different skills and qualities.
It does. It's a challenging but rewarding field.
It's inspiring to see the dedication and expertise
that CMC professionals bring to their work. It
really is. And it's a reminder that behind every
amazing new medicine, there's a team of unsung
heroes who work tirelessly to make it happen.
That's true. Speaking of unsung heroes, let's
talk about the importance of mentorship and training
in CMC. Okay. How do experienced professionals
pass on their knowledge and skills to the next
generation of CMC experts? Mentorship and training
are absolutely essential for ensuring that CMC
continues to be successful. OK. Experienced professionals
play a crucial role in guiding and developing
the next generation of CMC experts, sharing their
knowledge, insights, and best practices. So it's
about passing the torch, so to speak. Exactly.
Mentorship can take many forms, from formal training
programs to more informal one -on -one interactions.
Good. Senior CMC professionals often mentor junior
colleagues, providing guidance support and opportunities
for growth. So it's a very supportive and collaborative
environment. It is. And there are also professional
organizations like the American Association of
Pharmaceutical Scientists, or AAPS, and the Parental
Drug Association, PDO. They offer workshops,
conferences, and online resources to help share
knowledge and promote professional development
within the CMC community. So there's a real emphasis
on continuing education and professional growth
in this field. Absolutely. It's all about ensuring
that the field stays strong and attracts talented
people. It's heartwarming to see that commitment
to knowledge. and professional development. It
is. It's a reminder that the success of CMC depends
on the collaboration and mentorship of those
who came before us. That's right. We all stand
on the shoulders of giants. Speaking of collaboration,
let's talk about communication and teamwork in
CMC. Okay. How do different teams and disciplines
work together to make sure drug development is
successful? CMC is all about collaboration. It
requires clear communication and coordination
between different teams and disciplines. From
the very first step of making the drug substance
to the final step of packaging the drug product,
multiple teams are involved, each with their
own expertise and responsibilities. This is like
a complex puzzle with lots of different pieces.
Exactly. And good communication is essential
to make sure everyone is on the same page, that
information is shared openly, and that any potential
problems are identified and addressed quickly.
So everyone needs to be talking to each other
and working together. Exactly. Regular meetings,
clear documentation, and open lines of communication
are all crucial for creating a work environment
that's both collaborative and productive. It
sounds like a very organized and efficient process.
It needs to be. CMC teams also often have to
interact with people outside their own companies,
like... regulatory agencies, contract manufacturers,
and clinical trial sites. Clear and concise communication
is super important for building strong relationships
with these stakeholders and making sure drug
development goes smoothly. So communication is
key, both internally and externally. Absolutely.
It's at the heart of CMC, allowing different
disciplines and experts to work together seamlessly
to achieve a shared goal. It's inspiring to see
how different teams and individuals come together
to contribute to the development of new medicines.
It is, yeah. And it's a reminder that the success
of CMC depends on everyone involved pulling their
weight and working together. Speaking of everyone
involved, let's take a moment to acknowledge
the dedication and hard work of all CMC professionals.
Yes, they deserve a lot of credit. They're the
unsung heroes of drug development, working tirelessly
behind the scenes to make sure that new treatments
are safe, effective, and accessible to people
who need them. They are. And their work often
goes unnoticed, but it makes a huge difference.
It does. They're the foundation upon which medical
advancements are built. That's right. And their
work is essential for improving human health
and well -being. Absolutely. So let's express
our gratitude to all CMC professionals for their
invaluable contributions to the field of medicine.
Hemer here. Speaking of gratitude, I want to
thank you for joining us today and sharing your
insights into this amazing and complex world
of CMC. It's been my pleasure. Thanks for having
me. It's been an enlightening and inspiring conversation.
And to our listeners, thanks for tuning in to
the Deep Dive. We hope you've learned a lot about
the intricate processes and dedicated individuals
that make new medicines a reality. I hope so,
too. We encourage you to check out the show notes
for more information and resources on this topic.
Until next time. Keep diving deeper into the
wonders of science and innovation. Wow, we've
really covered a lot today, haven't we? Exploring
this whole world of preclinical CMC. From the
technical stuff, like how drugs are made and
analyzed, to the regulatory hurdles and the amazing
collaboration that makes this field work. But
before we go, I want to bring it back to our
listeners. Why should all this matter to someone
who's not a scientist? What's the takeaway for
the everyday person who might benefit from these
new treatments someday? That's a really good
question. I think the big takeaway is this. When
you see a new medicine approved and available,
it's easy to forget all the work that went into
making it happen. Preclinical CMC is a huge part
of that journey. It's all about making sure that
medicine is safe, effective, and consistently
produced to the highest standards. It's about
knowing that those medicines we rely on are trustworthy,
right? Absolutely. And it's a process that involves
careful planning testing and experts from all
different fields working together. It may not
be glamorous, but it's super important for delivering
quality health care. So next time you hear about
a new treatment that sounds promising, remember
all the folks working behind the scenes in CMC.
They may not be in the spotlight, but they're
a huge reason why we have these new medicines.
They really are the unsung heroes laying the
foundation for medical progress. And on that
note, I want to give a big thank you to you,
our expert, for joining us today and sharing
your incredible knowledge about this fascinating
world. It was my pleasure. Thanks for having
me. And to all our listeners, thank you for joining
us on the deep dive. We encourage you to explore
the show notes for more info and resources. Until
next time, keep diving deeper.